Dose/Strength | 2 mg |
Packaging Type | Vial |
Brand | Cadila |
Manufactured By | Cadila pharmaceutical |
Usage/Application | Hospital |
Shelf life | 36 |
Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma. Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells and multiple myeloma (a type of cancer of the bone marrow)., which are eventually destroyed by the body
Dose/Strength | 2 mg |
Packaging Type | Vial |
Brand | Cadila |
Manufactured By | Cadila pharmaceutical |
Usage/Application | Hospital |
Shelf life | 36 |
Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma. Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells and multiple myeloma (a type of cancer of the bone marrow)., which are eventually destroyed by the body